Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Metastatic Castration-Resistant Prostate Cancer”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Early research (Phase 1)WithdrawnNCT02182622
What this trial is testing

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

Who this might be right for
Prostate Cancer
Martin Gutierrez
Early research (Phase 1)Study completedNCT04397276
What this trial is testing

JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT02893917
What this trial is testing

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma With Neuroendocrine DifferentiationCastration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06609005
What this trial is testing

Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Advanced Metastatic Castration Resistant Prostate Cancer
Shenzhen Ionova Life Sciences Co., Ltd. 84
Not applicableStudy completedNCT03658486
What this trial is testing

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Queen's University, Belfast 30
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Testing effectiveness (Phase 2)Looking for participantsNCT06227156
What this trial is testing

Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
RemeGen Co., Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT00293371
What this trial is testing

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 6
Early research (Phase 1)Looking for participantsNCT05942001
What this trial is testing

Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT04100018
What this trial is testing

Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 1,030
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Early research (Phase 1)Looking for participantsNCT04729114
What this trial is testing

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration Resistant Prostate CancerMetastatic Castration-sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 174
Testing effectiveness (Phase 2)WithdrawnNCT02793765
What this trial is testing

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Ended earlyNCT03577028
What this trial is testing

Study of HPN424 in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 104
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Testing effectiveness (Phase 2)Looking for participantsNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 89
Not applicableEnded earlyNCT05301062
What this trial is testing

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels

Who this might be right for
Metastatic Castration-resistant Prostate CancerBone Metastases
Bayer 8
Early research (Phase 1)Not Yet RecruitingNCT07533708
What this trial is testing

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

Who this might be right for
mCRPC or Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech 48
Load More Results
90